Bio-Rad Laboratories Class BBIO.B
13F holders, Q4 2025 (December 31)6holders +1
1new positions
0sold out
$303.88avg. 13F price*
At the end of Q4 2025, 6 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were CSS LLC ($319K), Focus Partners Wealth ($227K) and Morgan Stanley ($208K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 8 shares bought and 69 shares sold, net −61 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| CSS LLC | 0.05% | Reduce -5.0% | 1,038 | $319K |
| Focus Partners Wealth | 0.00% | No change | 760 | $227K |
| Morgan Stanley | 0.00% | Reduce -2.1% | 697 | $208K |
| Wells Fargo & Company | 0.00% | No change | 170 | $53K |
| Whittier Trust Co. | 0.00% | No change | 160 | $52K |
| UBS Group AG | 0.00% | New | 8 | $2K |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.